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Factors associated with current and severe physical side-effects after 
prostate cancer treatment: what men report 
L Steentjes, S Siesling, F.J Drummond, J.G van Manen, L Sharp, A Gavin 
METHODS continued  
Outcome variables post treatment were:, incontinence, loss of 
libido, impotence, bowel problems, breast changes, hot flushes 
and fatigue.  
Men were grouped according to ‘early’ stage I/II and Gleason 
Grade (GG) 2-7 at diagnosis (localised) and ‘late’ stage III/IV and 
any GG at diagnosis (n=689) (locally advanced/advanced) disease 
at diagnosis. Univariate and multivariate logistic regression 
analysis were performed to identify patient and disease-related 
factors associated with current side-effects of any severity and (ii) 
severe side-effects ever experienced.  
Survivors with other combinations of stage and Gleason Grade 
(GG), or unknown stage or GG, were excluded from analysis 
(n=959) leaving 2,389 PCa survivors for analysis. 
Potential explanatory variables: age and comorbidities at 
diagnosis, highest level of education completed, jurisdiction (RoI, 
NI), pre-treatment symptoms, biopsy complications, TURPs and 
treatment ever had. Univariate and multivariate logistic regression 
analysis were performed to identify patient and disease-related 
factors associated with side-effects.  
stats 
To identify patient-related and disease-related characteristics that are 
associated with a range of current and ever experienced severe physical 
side-effects among prostate cancer survivors.   
Treatment is the most important factor associated with post-treatment 
side-effects with radical prostatectomy associated with most side 
effects and most severe side effects of all treatments. After treatment, 
various other factors such as pre-treatment function, comorbidities and 
a history of biopsy complications were strongly associated with a higher 
risk of side-effects. These findings may be used to better inform PCa 
patients and physicians about the potential side-effects associated with 
specific treatments and which patients may be at risk of these as well 
as informing strategies for post-treatment follow-up and monitoring. 
This could ultimately lead to better informed treatment decision-making 
and better support after treatment. 
Ref. Gavin AT, Drummond FJ, Donnelly C, O'Leary E, Sharp L, Kinnear HR.  Patient reported “ever 
had” and “current” long term physical symptoms following prostate cancer treatments.  BJU 
International 2015, Jan.  http://onlinelibrary.wiley.com/doi/10.1111. 
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Figure 1a: 'Current' side-effects in early and late disease (%) 
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Figure 1b: ‘Severe side-effects ever experienced’ in early and late 
disease (%) 
Factors associated with ‘severe’ side-effects ever experienced in 
early disease 
• RP was associated with a higher risk of hot flushes and fatigue 
and the side-effects mentioned for ‘current’. BT was associated 
with a lower risk of impotence (p<0.05). 
Factors associated with ‘current’ side-effects in late disease 
• Complications post-biopsy were  associated with a higher risk of 
sexual dysfunction (p<0.05). 
• Comorbidities at diagnosis is associated with a higher risk of 
incontinence, bowel problems and fatigue (p<0.05). 
Factors associated with ‘severe’ side-effects ever experienced in late 
disease 
• Complications post-biopsy were associated with higher risk of 
incontinence, hot flushes and fatigue (p<0.05). 
• Multiple comorbidities at diagnosis was associated with a higher 
risk of bowel problems and fatigue (p<0.05). 
 
 
 
Background:  
Prostate cancer (PCa), the second most common male cancer in the 
developed world is increasing. Ongoing side-effects post-treatment were 
reported by 75% of PCa survivors in population-based research (Ref 
below). 
Questionnaire survey to 6,937 PCa Survivors identified from 2 population 
based Cancer Registries on the Island of Ireland (National Cancer 
Registry of Ireland (RoI)  and N. Ireland Cancer Registry (NI) ) diagnosed 
2-18 years previously.  Survey included symptoms at diagnosis, primary 
treatments and physical side-effects - ever and current at time of 
questionnaire completion. Clinical staff checked eligibility of survivors for  
(I) aware of their PCa diagnosis, (II) well enough to complete a survey, (III) 
usually  a resident of RoI/NI and (IV) able to understand English.  
• ‘Current’ and ‘Ever Had’ side effects were more common in late than 
early disease (Fig 1a). 
• Severe side effects were common with impotence highest at 40% in 
early patients  and 53% in late PCa survivors (Fig 1b). 
Factors associated with ‘current’ side-effects in early disease 
• Radical Prostatectomy (RP) was associated with a higher risk of 
incontinence and Erectile dysfunction.  Brachy therapy (BT)was 
associated with a lower risk of fatigue while Active Surveillance 
/Watchful waiting  was associated with a lower risk of incontinence, 
sexual dysfunction, and fatigue (p<0.05). 
• Multiple comorbidities at diagnosis and complications post-biopsy 
were associated with a higher risk of bowel problems (p<0.05). 
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